Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

By sjmartinez • December 4, 2023

Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials. Kidney Med. 2023 Sep 28;5(12):100730. doi: 10.1016/j.xkme.2023.100730. PMID: 38046911; PMCID: PMC10692708.

Tags: Cardiorenal, Chronic kidney disease, Clinical Trial, Finerenone, Harbor UCLA, Nephrology, Publications, Race, Type 2 diabetes

From Niche to Norm: A Multi-Action Plan to Close Gaps and Mainstream Incremental Hemodialysis

Murea M, Torreggiani M, Deira J, Sirich TL, Viecelli AK, Vilar E, Suárez-Santisteban MÁ, Daugirdas JT, Farrington K, Kalantar-Zadeh K, Saudan P, Jaques DA, Foley[...]

Sex-Specific Coronary Artery Calcium Percentiles Across South Asian Adults: Combined Analyses From MASALA and DILWALE

Tasdighi E, Dardari Z, Whelton SP, Patel J, Kanaya AM, Budoff MJ, Javaid A, Kulkarni S, Ma TW, Butler J, Shah NS, Blaha MJ, Agarwala[...]

Correlation analysis of hematocrit level and coronary heart disease in patients with chest pain: a case-control study

Xie J, Cao H, Jin D, Wang Y, Li X, Budoff M, Jiang H, Ren J. Correlation analysis of hematocrit level and coronary heart disease[...]